VISMO trial to treat basal cell carcinoma

08:23 EDT 6 Sep 2016 | ecancermedicalscience

Dr Hauschild speaks with ecancertv at WCCS 2016 with updates from recent trials in checkpoint inhibition therapy. He discusses the Hedgehog inhibitor tested through the VISMO trial to treat basal cell carcinoma, and the BRIM trials of vemurafinib ±...

Original Article: VISMO trial to treat basal cell carcinoma


More From BioPortfolio on "VISMO trial to treat basal cell carcinoma"

Quick Search

Relevant Topic

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...